Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Neuromuscular Disorders : NMD
|
October 2, 2025
Applying the international rare disease research consortium (IRDiRC) N-of-1 therapy task force eligibility criteria for individualised therapies use case: Duchenne muscular dystrophy
Annemieke Aartsma-Rus, Anneliene H Jonker, Daniel O'Connor
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
March 29, 2017
Deciphering tissue morphodynamics using bioimage informatics
Alexandre C Dufour, Anneliene H Jonker, Jean-Christophe Olivo-Marin
The Lancet. Global Health
|
September 20, 2024
Access in the rare diseases landscape
Anneliene H Jonker, Maria Cavaller-Bellaubi, Yukiko Nishimura, et al.
European Journal of Medical Genetics
|
October 7, 2024
Lessons learned from the RE(ACT) conference on medical devices for rare diseases
Anneliene H Jonker, Tim Buckinx, Lucia Pannese, et al.
Nature Reviews. Drug Discovery
|
December 16, 2024
IRDiRC perspectives on the application of digital biomarkers in therapeutic development for rare diseases
Rajesh Krishna, Anneliene H Jonker, Thomas Morel, et al.
Drug Discovery Today
|
December 4, 2025
Non-oncology orphan drug development: Productivity and probability of success
Samantha Parker, Jida El Hajjar, Anneliene H Jonker, et al.
Nature Reviews. Drug Discovery
|
January 26, 2022
Research on rare diseases: ten years of progress and challenges at IRDiRC
Lucia Monaco, Galliano Zanello, Gareth Baynam, et al.
European Journal of Human Genetics : EJHG
|
October 27, 2016
'IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases
Hanns Lochmüller, Yann Le Cam, Anneliene H Jonker, et al.
European Journal of Human Genetics : EJHG
|
November 22, 2017
The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact
Hanns Lochmüller, Josep Torrent I Farnell, Yann Le Cam, et al.
Clinical and Translational Science
|
August 11, 2017
Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective
Hugh J S Dawkins, Ruxandra Draghia-Akli, Paul Lasko, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Neuromuscular Disorders : NMD
|
October 2, 2025
Applying the international rare disease research consortium (IRDiRC) N-of-1 therapy task force eligibility criteria for individualised therapies use case: Duchenne muscular dystrophy
Annemieke Aartsma-Rus, Anneliene H Jonker, Daniel O'Connor
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
March 29, 2017
Deciphering tissue morphodynamics using bioimage informatics
Alexandre C Dufour, Anneliene H Jonker, Jean-Christophe Olivo-Marin
The Lancet. Global Health
|
September 20, 2024
Access in the rare diseases landscape
Anneliene H Jonker, Maria Cavaller-Bellaubi, Yukiko Nishimura, et al.
European Journal of Medical Genetics
|
October 7, 2024
Lessons learned from the RE(ACT) conference on medical devices for rare diseases
Anneliene H Jonker, Tim Buckinx, Lucia Pannese, et al.
Nature Reviews. Drug Discovery
|
December 16, 2024
IRDiRC perspectives on the application of digital biomarkers in therapeutic development for rare diseases
Rajesh Krishna, Anneliene H Jonker, Thomas Morel, et al.
Drug Discovery Today
|
December 4, 2025
Non-oncology orphan drug development: Productivity and probability of success
Samantha Parker, Jida El Hajjar, Anneliene H Jonker, et al.
Nature Reviews. Drug Discovery
|
January 26, 2022
Research on rare diseases: ten years of progress and challenges at IRDiRC
Lucia Monaco, Galliano Zanello, Gareth Baynam, et al.
European Journal of Human Genetics : EJHG
|
October 27, 2016
'IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases
Hanns Lochmüller, Yann Le Cam, Anneliene H Jonker, et al.
European Journal of Human Genetics : EJHG
|
November 22, 2017
The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact
Hanns Lochmüller, Josep Torrent I Farnell, Yann Le Cam, et al.
Clinical and Translational Science
|
August 11, 2017
Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective
Hugh J S Dawkins, Ruxandra Draghia-Akli, Paul Lasko, et al.
Page
of 2